Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - GRYSKA DAVID W
Last Updated 
20-May-15
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

GRYSKA DAVID W: Declared Holdings
Company/RelationshipReportedShares  Ownership
Aerie Pharmaceuticals, Inc.
Director
NasdaqGM:AERI
(historical quotes, profile, other insiders)
10-Apr-151,700  Direct
Incyte Corporation
Officer
NasdaqGS:INCY
(historical quotes, profile, SEC, other insiders)
8-Jan-1510,850  Direct
PDL BioPharma, Inc.
Director
NasdaqGS:PDLI
(historical quotes, profile, SEC, other insiders)
28-May-1411,352  Direct
Seattle Genetics, Inc.
Director
NasdaqGS:SGEN
(historical quotes, profile, SEC, other insiders)
15-May-1533,950  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
15-May-15 3,700SGEN Acquisition (Non Open Market) at $0 per share.
10-Apr-15 1,700AERI Acquisition (Non Open Market) at $0 per share.
8-Apr-15 5,000SGEN Option Exercise at $8.38 per share.
(Cost of $41,900)
8-Jan-15 3,022INCY Acquisition (Non Open Market) at $0 per share.
31-Oct-14 7,828INCY Acquisition (Non Open Market) at $0 per share.
28-May-14 5,371PDLI Acquisition (Non Open Market) at $9.31 per share.
(Value of $50,004)
16-May-14 3,500SGEN Acquisition (Non Open Market) at $0 per share.
6-Mar-14 5,981PDLI Acquisition (Non Open Market) at $8.36 per share.
(Value of $50,001)
3-Sep-13 10,000SGEN Sale at $42.48 per share.
(Proceeds of $424,799)
3-Sep-13 10,000SGEN Option Exercise at $10.08 per share.
(Cost of $100,800)


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?